Epidemiology of Neuropsychiatric Disorders Unit

In December 2015, the unit (formerly: „Epidemiology in Patient Populations”) shifted its research focus to questions regarding the epidemiology of neuropsychiatric disorders.

Neurological and psychiatric disorders are increasingly important in our society, primarily due to the demographic change and increasing incidence rates of such disorders in children and adolescents. Currently, about 38% of EU citizens (165 million) suffer from at least one disease from the neuropsychiatric spectrum. More than 42% of all lost years of life or years spent with a disability in the EU can be attributed to neuropsychiatric disorders. This means that neuropsychiatric diseases are the main cause of disability and impairment of quality of life and ability to function.

Current research topics of the unit are neuropsychiatric disorders in childhood and in late adulthood, for example, attention-deficit/ hyperactivity disorder in children or neurodegenerative disorders frequently occurring in elderly people (e.g., Parkinson's disease, Alzheimer's disease). Since these diseases are also a burden for relatives of the affected individuals, which in turn increases the relatives’ risk of neuropsychiatric disorders, a future research topic of the unit will focus on this group. Depending on the concrete research question, synergies with other units of the department are generated (e.g., with the Drug Safety Unit, regarding investigations of adverse events during treatment with psychotropic drugs).

Selected publications

    Articles with peer-review

  • Riedel O, Wittchen H-U, IDEA Studiengruppe. Nutzer und Nutzung von Selbsthilfegruppen für pflegende Angehörige von Alzheimer-Patienten. Ergebnisse einer naturalistischen Beobachtungsstudie. Zeitschrift für Gerontologie und Geriatrie. 2017;50(1):14-20.
  • Kersting C, Lindemann C, Jacobi C, LoBaido A, Schneider A, Yurdakul M, Ziegler-Kirbach E, Mikolajczyk R, Garbe E. Therapieziele von Kindern und Jugendlichen mit ADHS und ihren Hauptbezugspersonen. Eine inhaltsanalytische Auswertung und Prüfung der Übereinstimmung zwischen Betroffenen und Bezugspersonen. Das Gesundheitswesen. 2016;78(1):34-36.
  • Kersting C, Lindemann C, Mikolajczyk R, Garbe E, Riedel O. Auf dem Weg zu einer optimale(re)n Versorgung? Ergebnisse der Pilotierung eines ADHS-Selektivvertrages nach §73c SGB V in Bremerhaven. Psychotherapie, Psychosomatik, Medizinische Psychologie. 2016;66(5):187-194.
  • Riedel O, Bitters D, Amann U, Garbe E, Langner I. Estimating the prevalence of Parkinson's disease (PD) and proportions of patients with associated dementia and depression among the older adults based on secondary claims data. International Journal of Geriatric Psychiatry. 2016;31(8):938-943.
  • Riedel O. Pflegebedürftigkeit bei Morbus Parkinson - zu selten (an-)erkannt? Das Gesundheitswesen. 2015;77(6):432-435.
  • Mikolajczyk R, Horn J, Schmedt N, Langner I, Lindemann C, Garbe E. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: A case-only study. JAMA Pediatrics. 2015;169(4):391-395.
  • Riedel O, Klotsche J, Wittchen H-U. Motor impairment, depression, dementia: Which forms the impression of disease severity in Parkinson's disease? Parkinsonism & Related Disorders. 2014;20(12):1365-1370.

Current projects

Es werden nur momentan laufende Projekte angezeigt oder solche, die vor weniger als einem Jahr endeten. Die Einträge sind alphabetisch sortiert.


Riedel, Oliver, PD Dr.
Tel.: +49 (0)421 218-56883
Fax: +49 (0)421 218-56941

Scholle, Oliver
Tel.: +49 (0)421 218-56878
Fax: +49 (0)421 218-56941